Post by Wolfgang Bernhart

Fifteen critical minerals sit under both US and Chinese export controls simultaneously – and European companies can't comply with both. When you restructure gallium sourcing to satisfy US rules, you trigger Chinese licensing oversight. When you document graphite traceability for US procurement, you expose your Chinese JV to ECL scrutiny. This is structural entrapment, not regulatory complexity. The execution window is eighteen months. Most companies treat this as a procurement problem. It's not. It's a capital allocation crisis masquerading as compliance. Non-Chinese graphite costs 40-80% more. Heavy rare earths cost more still. These aren't line items - they're budget decisions that require board approval and most European companies haven't made them. The timeline is what concerns me. China compressed a decade of adjustment into eighteen months through five systematic waves starting August 2023. European planning cycles assume you have years for this type of shift. You don't. The EU's Critical Raw Materials Act targets 2030 while Chinese controls on all fifteen dual-listed minerals are operational today. The only effective response is D7 coordination as proposed by former NATO Secretary General Anders Fogh Rasmussen - Australia, Canada, EU, Japan, New Zealand, South Korea, UK acting together. Brussels can't face Beijing's retaliation alone with €21 billion in automotive exposure. But that political threshold doesn't exist yet and companies can't wait for it. Supply chain bifurcation at product architecture level isn't a future project. It's a capital commitment required now or market access closes before you finish planning. Defense contractors have already subordinated materials sourcing to US regulatory approval. Battery manufacturers face the same choice. Automotive OEMs with China exposure can't run dual compliance on a single platform. The companies that treat this as regulatory overhead will lose market access before their compliance teams finish the review. Are you budgeting supply chain bifurcation as strategic capital investment or managing it as regulatory risk? Roland Berger Rachel Hugo David Frans Ellen Carey Martin Seiwert Hauke Friederichs Steinhausen Markus Robina von Stein Elisabeth Behrmann Franz Anko-Hubik Michael Freitag Doreen Rietentiet Jarkko Vesa Jens Schröder Kristina Gnirke Adrienne Fichter Ernest Scheyder Ulrich Schäfer Colum Murphy Prof. Dr. Torsten Oltmanns Simone Peter Dr. David Born Spencer Gore Anas Hanan Ekke Van Vliet Lieven MachielsAntoine BONDAZ, Ph.D. João Saint-Aubyn Carl Kuehl Christian T. Marcus Wolf Eyk Henning BDI - Bundesverband der Deutschen Industrie e.V. Dr. Frank Hiller Prof. Dr. Hermann Eul Reinhard Ploss Bernd Bohr Dr. Martin Brudermüller Dr. Karl-Thomas Neumann #CriticalMinerals #SupplyChainSovereignty #GeopoliticalRisk #EuropeanSovereignty #DOMINANCEAct #D7Alliance #StrategicAutonomy #ExportControls #RareEarthElements #EUChina #IndustrialPolicy #LithiumIonBatteries